Aktieanalys

Kontigo Care Q4 2022 initial take: Regained growth - Redeye

{newsItem.title}

Redeye Publicerad: 03 Feb 2023 09:49

Redeye comments on Kontigo Cares Q4'22 report, in which Net Sales (SEK7.2m) align with our expectations. OPEX exceeded expectations, but we are encouraged to see the active license base grow again.

Länk till analysen i sin helhet: https://www.redeye.se/research/873736/kontigo-care-q4-2022-initial-take-regained-growth?utm_source=finwire&utm_medium=RSS

Nyheter om Kontigo Care

Läses av andra just nu

Om aktien Kontigo Care

Senaste nytt